The current status of artisanal cannabis for the treatment of epilepsy in the United States
Authors:
- 1 May 2017
- journal article
- case report
- Published by Elsevier in Epilepsy & Behavior
- Vol. 70, 328-333
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disordersSeizure: European Journal of Epilepsy, 2010
- Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid systemNeuropharmacology, 2009
- Adverse antiepileptic drug effectsNeurology, 2009
- Adverse effects of medical cannabinoids: a systematic reviewCanadian Medical Association Journal, 2008
- Refractory Epilepsy: Clinical OverviewEpilepsia, 2007
- Detection of Δ9‐tetrahydrocannabinolic acid A in human urine and blood serum by LC‐MS/MSJournal of Mass Spectrometry, 2007
- CB1 Cannabinoid Receptors and On-Demand Defense Against ExcitotoxicityScience, 2003
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000